Medifast Unit To Fork Over $4M To FTC Over Weight-Loss Ads
Medifast Inc. subsidiary Jason Pharmaceuticals Inc. has agreed to pay $3.7 million under a proposed deal to resolve the U.S. Federal Trade Commission's probe of advertising claims for its weight-loss programs,...To view the full article, register now.
Already a subscriber? Click here to view full article